We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current MGRX market cap is 9.15M. The company's latest EPS is USD -1.6843 and P/E is -1.07.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 244k | 214k | 163k | 134k | 105k |
| Operating Income | -2.57M | -2.37M | -2.17M | -1.76M | -2.4M |
| Net Income | -2.57M | -2.37M | -2.39M | -2M | -1.95M |
| Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 9k | 731k | 616k |
| Operating Income | -18k | -1.99M | -9.22M | -8.69M |
| Net Income | -18k | -2M | -9.21M | -8.71M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 1.05M | 301k | 15.24M | 14.79M | 15.37M |
| Total Liabilities | 276k | 1.26M | 1.41M | 1.4M | 1.43M |
| Total Equity | 775k | -958k | 13.83M | 13.39M | 13.95M |
| Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 23k | 1M | 1.05M | 15.37M |
| Total Liabilities | 40k | 389k | 276k | 1.43M |
| Total Equity | -17k | 614k | 775k | 13.95M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -7M | -991k | -2.57M | -3.73M | -4.86M |
| Investing | -4k | N/A | 65k | 65k | 65k |
| Financing | 7.06M | 267k | 2.26M | 3.01M | 4.13M |
| Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -18k | -1.35M | -7M | -4.86M |
| Investing | N/A | -43k | -4k | 65k |
| Financing | 41k | 2.05M | 7.06M | 4.13M |
| Market Cap | 9.15M |
| Price to Earnings Ratio | -1.07 |
| Price to Sales Ratio | 15.1 |
| Price to Cash Ratio | 157.89 |
| Price to Book Ratio | 0.67 |
| Dividend Yield | - |
| Shares Outstanding | 5.17M |
| Average Volume (1 week) | 571.21k |
| Average Volume (1 Month) | 228.9k |
| 52 Week Change | -57.06% |
| 52 Week High | 16.80 |
| 52 Week Low | 1.485 |
| Spread (Intraday) | 0.04 (2.21%) |
| Company Name | Mangoceuticals Inc |
| Address |
15110 n. dallas parkway, suite 600 dallas, texas 75248 |
| Website | https://www.mangorx.com |
| Industry | health & allied services,nec (8099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
